Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pulmonary/Respiratory Diseases | Trauma/Emergency Medicine | Immunology/Infectious Diseases
Disease Category: COPD (Chronic Obstructive Pulmonary Disease)
Trial Information
A phase 2 B dose ranging research study to evaluate the response efficacy and safety of five doses of an investigational once daily inhaled dry powder compared to placebo in subjects with COPD.
This is a 7 week research study requiring a minimum of 9 clinic visits. The study will require blood work as well as EKGs and pulmonary function tests.
Patient Inclusion Criteria: All patients must have a clinical diagnosis of COPD, be male or female, current or former smokers and be between the ages of 40 and 80.
Patient Exclusion Criteria: Patients may not have sleep apnea that requires CPAP or a severe disease that requires the use of long term oxygen.
Jessica Elkins RN, CCRC, Director of Clincal Research
Emerald Coast Research Associates
221 East 23rd Street, Suite B
Panama City, FL 32405
Phone: 850-785-6550
Fax: 850-785-6804
EMail: jesselkins@bellsouth.net
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
